RSSSumitomo Chemical America Inc.
Company Information
The origins of Sumitomo Chemical can be traced back to 1913 when the company used sulfur dioxide emissions from the Besshi Copper Mine in the Shikoku region of Japan to produce calcium superphosphate fertilizers, thereby reducing pollution from the mine. In addition to helping preserve the environment by preventing the emission of pollutants, the company was thereby also able to contribute toward increasing the harvest of agricultural products. Sumitomo Chemical thus found its start with the solving of environmental problems and the goal of improving living standards. Today, the Sumitomo Chemical Group includes some 100 companies operating around the world in six business sectors: basic chemicals, petrochemicals and plastics, fine chemicals, IT-related chemicals, agricultural chemicals, and pharmaceuticals. Sumitomo Chemical's U.S. headquarters is based in New York. The parent headquarters is located in Tokyo, Japan. The majority of the company's sales is based in the petrochemicals sector, comprising 32% of total company sales.
Company Officers
Hiromasa Yonekura
president of Sumitomo Chemical Co.
Yonekura has been serving as president, executive president and representative director in Sumitomo Chemical Co. Ltd., as well as president of its subsidiary since June 2003, according to Reuters news service. He also serves as director for AOC Holdings Inc. and vice chairman of an associated company. He joined the company in April 1960. His previous titles include director of business planning office, managing director, senior managing director and director.
Hiroshi Hirose
executive vice president
Hirose has been serving as executive vice president and representative director of Sumitomo Chemical Co. Ltd. since June 2008, according to Reuters. He is also serving as director of an associated company, Inabata & Co. Ltd. He joined the company in April 1967. His previous titles include senior managing executive officer, director of General Affairs, executive officer, managing executive officer and director of the company.
Yasuo Kamei
senior managing executive officer and representative director
Kamei has been serving as Senior Managing Executive Officer and Representative Director in Sumitomo Chemical Co. Ltd.. since June 22, 2007, according to Reuters. He joined the company in April 1969. His previous titles include director of Inorganic Industrial Chemical Business, executive officer, managing executive officer and director of the company.
Investor Information
For the latest financial reports, visit: http://www.sumitomo-chem.co.jp/english/ir/index.html
Contact Information
- Sumitomo Chemical America Inc.
- 335 Madison Ave Rm 830
- New York, N.Y. 10017-4621
- www.sumitomo-chem.co.jp/english/
Featured content related to Sumitomo Chemical America Inc.
Sumitomo Chemical America Inc. News
Sumitomo Chemical America Inc. Articles
Products
Sumitomo Chemical supplies basic materials to various industries ranging from consumer-goods to high-tech. Its product line includes inorganic and organic industrial chemicals, composite materials, polymethyl methacrylate resin and sheets, and aluminum. The company supplies many kinds of petrochemical products including organic chemicals, plastics such as low-density polyethylene and polypropylene, and synthetic rubber.. The company offers a wide array of specialty products, including organic intermediates and additives, dyestuffs, and functional materials. The IT-related chemicals sector comprises the Optical Materials division,, the Semiconductor Process Materials division and the Electronic Materials division. Sumitomo Chemical has developed a number of plant protection chemicals, ranging from conventional insecticides, fungicides and herbicides to new types of products, including plant growth regulators. These products are marketed in more than 110 countries around the world. Sumitomo Chemical's pharmaceutical business originated from organic synthesis, a technology that was mainly used for dyestuffs until Sumitomo used the technology to make Japan's first synthetic medicines. Sumitomo Chemical's pharmaceutical business is operated by Sumitomo Pharmaceuticals Co., which mainly manufactures and sells prescription drugs, and Nihon Medi-physics Co. Ltd., which manufactures and sells diagnostics.
